700 Main Street
Aquinnah Pharmaceuticals is committed to restoring the health of people with ALS, Alzheimer's and other neurodegenerative diseases. They have developed a revolutionary approach that has the potential to arrest, and possibly even reverse, these diseases. Aquinnah was chosen as the Most Innovative Neurodegenerative Research Company in 2016 by New Economy Magazine.
Founder and CEO: Glenn Larsen
Founder and CSO: Ben Wolozin
Please click here for Aquinnah job opportunities.